Arnaud Scherpereel (Lille, France), Rudolf M. Huber (München, Germany), Tuncay Göksel (Izmir, Turkey)
Reactive oxygen species modulator 1 (Romo1) as a diagnostic marker for lung cancer-related malignant effusion Seung Hyeun Lee (Seoul, Republic of Korea), Seung Hyeun Lee, Sue In Choi, Won Jai Jung, Eun Joo Lee, Kyung Hoon Min, Gyu Young Hur, Seung Heon Lee, Sung Yong Lee, Je Hyeong Kim, Sang Yeub Lee, Chol Shin, Jae Jeong Shim, Kyung Ho Kang, Kwang Ho In
| |
Rhesus CE expression is an independent prognostic factor in non-small cell lung cancer Arik Bernard Schulze (Münster, Germany), Arik Bernard Schulze, Lars Henning Schmidt, Lara Baie, Andreas Kuemmel, Michael Mohr, Hartmut Hillmann, Georg Geißler, Dennis Görlich, Reinhard Kelsch, Rainer Wiewrodt
| |
Expression of the ILK-PINCH-PARVIN (IPP) complex and its binding partner Rsu-1 in human non-small cell lung cancer Sofia Nikou (Patra, Greece), Sofia Nikou, Theodora Agalioti, Georgios Stathopoulos, Ioanna Giopanou, Vassiliki Zolota, Helen Papadaki, Vassiliki Bravou
| |
Metaanalysis of ROS1-positive lung cancer cases Rica Zinsky (Wiesbaden, Germany), Rica Zinsky
| |
Expression and clinical significance of S100 calcium binding protein A2 in lung cancer Hui Ren (Xi'an, China), Hui Ren, Ting Wang, Mingwei Chen
| |
Association between leptin and risk of lung cancer Xiang Tong (Chengdu, China), Xiang Tong, Yao Ma, Zhipeng Yan, Hong Fan
| |
Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Tuncay Göksel (Izmir, Turkey), Levent Pelit, Tuncay Göksel, Tugberk Nail Dizdas, Ilknur Bagatir, Füsun Pelit, Özlem Göksel, Hasan Ertas, Hülya Samancioglu, Burak Ordin, Arif Gürsoy, Durmus Özdemir, Haydar S. Karakus, Münevver Erdinç, F. Nil Ertas
| |
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Luis Mur (Aberystwyth, United Kingdom), Adian Mironas, Simon Cameron, Keiron O’Shea, Paul Lewis, Luis Mur, Keir Lewis
| |
Diaphragm invasion worsen the prognosis as indicated in the 8th TNM Cagatay Tezel (Istanbul, Turkey), Cagatay Tezel, Mustafa Akyil, Serdar Evman, Serda Kanbur, Talha Dogruyol, Levent Alpay, Cansel Atinkaya Ozturk, Volkan Baysungur, Irfan Yalcinkaya
| |
The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer Seung Soo Yoo (Daegu, Republic of Korea), Seung Soo Yoo, Hyo-Gyoung Kang, Jin Eun Choi, Sun Ha Choi, So Yeon Lee, Shin Yup Lee, Jaehee Lee, Seung Ick Cha, Chang Ho Kim, Jae Yong Park
| |
Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing Ina Iuliana Macovei (Pavel) (Iasi, Romania), Ina Iuliana Macovei, Ionut Pavel, Radu Zonda, Simona Péter, Florin Rusu-Cordunean, Andrei Tudor Cernomaz, Bogdan Dragos Grigoriu
| |
Interobserver variability of tumor proliferation index and the importance of semiautomated method for counting Ki-67 in lung carcinoma Cristian Suciu (Timisoara, Romania), Cristian Suciu, Cristian Oancea, Ovidiu Burlacu, Remus Cornea, Oana Suciu, Marius Raica
| |
Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients Clotilde Fournier (Marseille, France), Clotilde Fournier, Pascale Tomasini, Anderson Loundou, Laurent Greillier, Fabrice Barlesi
| |
Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer Ghassen Soussi (Boumhal, Tunisia), Ghassen Soussi, Hajer Racil, Nissaf Ben Alaya, Abdellatif Chabbou
| |
LATE-BREAKING ABSTRACT: Improving the quality of pathological diagnosis of NSCLC in England Neal Navani (London, United Kingdom), Neal Navani, Paul Beckett, Susan Harden, Aamir Khakwani, Rosie Dickinson, Richard Hubbard, Ian Woolhouse
| |
LATE-BREAKING ABSTRACT: Treatment efficacy of afatinib vs gefitinib in lung adenocarcinoma with EGFR gene mutation Marisol Arroyo Hernandez (Oaxaca, Mexico), Marisol Arroyo Hernandez, Alexander J. Alatorre, Julio C. Garibay, José F. Escobar, Jerónimo Rodríguez
| |